Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
03/2014
03/26/2014CN103664798A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664797A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN103664734A Heterocyclic hydroxamic acid compound as well as pharmaceutical composition and application thereof
03/26/2014CN103664697A Chemical method used for preparing aromatic cyclopropanecarbonitrile and cyclopropylamine
03/26/2014CN102485718B Sitagliptin intermediate and its preparation method
03/26/2014CN102015708B Pyrimidyl cyclopentanes as AKT protein kinase inhibitors
03/25/2014US8680291 Diarylhydantoin compounds
03/25/2014US8680271 Process for synthesizing 6-bromo-3-1-(1-methyl-1H-pyrazol-4-yl)-5-(3(R)-piperidinyl)pyrazolo[1,5-a]pyrimidin-7-amine
03/25/2014US8680266 Metallocorroles
03/25/2014US8680265 Process for the preparation of a boron-substituted porphyrin
03/25/2014US8680113 BMI-1 protein expression modulators
03/25/2014US8680107 Activators and therapeutic applications thereof
03/25/2014US8680099 6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of CNS disorders
03/25/2014US8680098 Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators
03/25/2014US8679459 B ring reduced-D ring oxidized tetrapyrrolic photosensitizers for photodynamic therapy and tumor imaging
03/25/2014CA2735177C Saturated bicyclic heterocyclic derivatives as smo antagonists
03/25/2014CA2617099C Macrocyclic inhibitors of hepatitis c virus
03/25/2014CA2563699C Kinase modulators and method of use
03/20/2014WO2014043272A1 Tricyclic gyrase inhibitors for use as antibacterial agents
03/20/2014WO2014043148A1 An improved process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine from 4-amino-2,5-dimethoxypyrimidine
03/20/2014WO2014043087A1 Process for the preparation of 2-amino-5,8-dimethoxy[1,2,4]triazolo[1,5-c]pyrimidine from 4-chloro-2,5-dimethoxypyrimidine
03/20/2014WO2014042405A1 A novel combination of a host compound and a dopant compound and an organic electroluminescence device comprising the same
03/20/2014WO2014042263A1 Novel renin inhibitor
03/20/2014WO2014041131A1 Tricyclic quinoline and quinoxaline derivatives
03/20/2014WO2014041125A1 Specific inhibitors of protein p21 as therapeutic agents
03/20/2014US20140081026 Process for the production of sitagliptin
03/20/2014US20140081024 PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE FROM 4-AMINO-2,5-DIMETHOXYPYRIMIDINE
03/20/2014US20140081023 PROCESS FOR THE PREPARATION OF 2-AMINO-5,8-DIMETHOXY[1,2,4]TRIAZOLO[1,5-c]PYRIMIDINE FROM 4-CHLORO-2,5-DIMETHOXYPYRIMIDINE
03/20/2014US20140081018 Method for preparation of fluorine-18-labeled flumazenil using diaryliodonium salt precursor
03/20/2014US20140080884 Novel crystalline forms of a dipeptidyl peptidase-iv inhibitor
03/20/2014US20140080860 Novel hybrid cholinesterase inhibitors
03/20/2014US20140080844 Inhibitors of bruton's tyrosine kinase
03/20/2014US20140080843 Methods for inhibiting fascin
03/20/2014US20140080821 Pyrimido-pyrrolo-oxazine-dione compound inhibitors of the cystic fibrosis transmembrane conductance regulator protein and uses therefor
03/20/2014US20140080816 Tricyclic quinoline and quinoxaline derivatives
03/20/2014US20140080814 Tricyclic quinoline and quinoxaline derivatives
03/20/2014US20140080806 Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors
03/20/2014US20140080801 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/20/2014US20140080797 Substituted porphyrins
03/20/2014US20140080780 identification of compounds that disperse tdp-43 inclusions
03/20/2014US20140079666 Pyrimidinone compounds and methods for preventing and treating influenza
03/19/2014EP2708540A1 Pyrimido-diazepinone compound
03/19/2014EP2708539A1 Annulated pyrimidines and triazines and their use
03/19/2014EP2708538A1 Process for preparing fused pyrimidine-dione derivatives, useful as as TRPA1 modulators
03/19/2014EP2707372A2 Spiro-oxindole mdm2 antagonists
03/19/2014EP2707371A1 New hexahydropyrroloimidazolone compounds
03/19/2014EP2707370A1 NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES
03/19/2014EP2707369A1 Compositions and methods for treating alzheimer's disease
03/19/2014CN103649093A Substituted imidazopyridines and imidazopyridazines and the use thereof
03/19/2014CN103649092A Imidazole derivative
03/19/2014CN103649091A Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
03/19/2014CN103649090A Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof
03/19/2014CN103649089A Pyrrolotriazinone derivatives as PI3K inhibitors
03/19/2014CN103649080A Nitrogenated aromatic heterocyclic derivative, and organic electroluminescent element using same
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103642488A Preparation method and application of multiple-tooth pyridine quinoxaline based fluorescence probe
03/19/2014CN103642299A Application of benzoheterocycle alkaloids in preparation of marine organism stain preventing coatings
03/19/2014CN103641838A Method for extraction of chlorophyll from Lactuca sativa
03/19/2014CN103641837A Method for extracting sodium copper chlorophyll from silkworm excrement
03/19/2014CN103641836A Preparation method of 2-methyl triethylene diamine
03/19/2014CN103641835A AZapyrenes For Electronic Applications
03/19/2014CN103641834A Pyrrolobenzodiazepine compounds, and preparation method and application thereof
03/19/2014CN103641833A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641832A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641831A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641830A Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/19/2014CN103641829A Triazole derivatives as kinase inhibitors
03/19/2014CN103641816A Compounds and compositions as protein kinase inhibitors
03/19/2014CN103641768A Phenylindole high iodine salt compound, and preparation method and use thereof
03/19/2014CN103641763A Procede de preparation de derives de porphyrine, telle que la protoporphyrine (ix) et intermediaire de synthese
03/19/2014CN103638887A Phthalocyanine compound synthesizer
03/19/2014CN103638529A Preparation method of medicament for enriching blood
03/19/2014CN102712652B Copolymer containing fluorenylporphyrin-benzene, preparation method and use thereof
03/19/2014CN102686591B Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
03/19/2014CN102633802B Intermediate for synthesizing 2-chloro-7H-pyrrolo (2, 3-d) pyrimidine and preparation method thereof
03/19/2014CN102131788B Compounds and compositions as protein kinase inhibitors
03/19/2014CN101874080B Improved shading process
03/18/2014US8674095 Compounds for treating neuropsychiatric conditions
03/18/2014US8674088 Antiviral phosphinate compounds
03/18/2014US8673959 Polymer having indolocarbazole moiety and divalent linkage
03/18/2014US8673958 Fullerene derivatives
03/18/2014US8673933 JAK2 inhibitors and their use for the treatment of myeloproliferative diseases and cancer
03/18/2014US8673932 Oxime substituted imidazo-containing compounds
03/18/2014US8673928 Compounds and methods for kinase modulation, and indications therefor
03/18/2014US8673925 Tyrosine kinase inhibitors
03/18/2014US8673924 Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
03/18/2014US8673923 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
03/18/2014US8673920 Inhibitors of the renal outer medullary potassium channel
03/18/2014US8673896 Benzodiazepine and pyridodiazepine derivatives
03/18/2014US8673895 Tetrahydro-pyrimidoazepines as modulators of TRPV1
03/18/2014CA2665075C High-purity large-scale preparation of stannsoporfin
03/18/2014CA2608974C Substituted 7,8-dihydro-1h-pyrimido[4,5-b][1,4]diazepin-4-amines are novel kinase inhibitors
03/13/2014WO2014039899A1 Pyrazolopyrimidine compounds as kinase inhibitors
03/13/2014WO2014039831A1 SUBSTITUTED-1,4-DIHYDROPYRAZOLO[4,3-b]INDOLES
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039714A2 Compounds and methods for kinase modulation, and indications therefor
03/13/2014WO2014039595A1 Imidazopyridazine jak3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
03/13/2014WO2014038606A1 Crystal of dispiropyrrolidine derivative
03/13/2014WO2014037751A1 Pharmacologically active compounds
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 573